Drawing for TSELLEX

USPTO serial 79093497

TSELLEX

Reviewed by CopyMark Law Group

Reg. 4081874Status 404
Filing date
Status date
Registration date
Jan 10, 2012
Examiner
I, DAVID C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TSELLEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Alumit

John Alumit ALUMIT IP135 South Jackson Street, Suite 200Glendale, CA 91205UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations in the field of neurology for the treatment of acute strokes of the ischemic and haemorrhagic type in the acuity and early rehabilitation period, encephalitis and encephalomyelitis, infantile cerebral paralysis (ICP), encephalopathy of the vascular, traumatic, toxic, and perinatal types, neuropsychic disorders, and perinatal encephalopathy; Pharmaceutical preparations in the field of neurosurgery for the treatment of traumatic affection of the central nervous system; Pharmaceutical preparations in the field of obstetrics and neonatology for the treatment of cerebral birth injury, hypoxemia and asphyxia, and for improvement of the pre-natal condition of the fetus; Pharmaceutical preparations in the field of reanimatology for the treatment of expressed impairment of consciousness; Pharmaceutical preparations in the field of rehabilitology for the treatment of the consequences of traumatic, vascular, toxic, and infectious affection of the central nervous system; Pharmaceutical preparations for psychostimulation for use as an adaptogene, and in anesthesiology, for activation of the central nervous system in the postanesthetic recovery period; veterinary preparations in the field of neurology for the treatment of acute strokes of the ischemic and haemorrhagic type in the acuity and early rehabilitation period, encephalitis and encephalomyelitis, infantile cerebral paralysis (ICP), encephalopathy of the vascular, traumatic, toxic, and perinatal types, neuropsychic disorders, and perinatal encephalopathy; veterinary preparations in the field of neurosurgery for the treatment of traumatic affection of the central nervous system; veterinary preparations in the field of obstetrics and neonatology for the treatment of cerebral birth injury, hypoxemia and asphyxia, and for improvement of the pre-natal condition of the fetus; veterinary preparations in the field of reanimatology for the treatment of expressed impairment of consciousness; veterinary preparations in the field of rehabilitology for the treatment of the consequences of traumatic, vascular, toxic, and infectious affection of the central nervous system; veterinary preparations for psycho stimulation for use as an adaptogene, and in anesthesiology, for activation of the central nervous system in the postanesthetic recovery period; Hygienic preparations for medical purposes, namely, for reparation of mucous membranes after damageSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 2, 2021DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 2, 2021DETHDEATH OF INTERNATIONAL REGISTRATION
Jun 28, 2019INNTTOTAL INVALIDATION PROCESSED BY THE IB
May 8, 2019XXSSGENERIC MADRID TRANSACTION SENT TO IB
May 8, 2019XXCRGENERIC MADRID TRANSACTION CREATED
Apr 17, 2019INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 17, 2018C71TCANCELLED SECTION 71
Jan 10, 2017REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 22, 2012FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Sep 14, 2012TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 5, 2012FICSFINAL DISPOSITION NOTICE SENT TO IB
Sep 4, 2012FIMPFINAL DISPOSITION PROCESSED
Aug 25, 2012FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 10, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 25, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 25, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 22, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 21, 2011ALIEASSIGNED TO LIE
Sep 8, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 7, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 6, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 6, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 9, 2011RFNTREFUSAL PROCESSED BY IB
Mar 18, 2011RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 17, 2011RFRRREFUSAL PROCESSED BY MPU
Mar 16, 2011RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 15, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 12, 2011MAFRAPPLICATION FILING RECEIPT MAILED
Mar 8, 2011DOCKASSIGNED TO EXAMINER
Mar 8, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 3, 2011REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance